CYP19A1 and hyperinsulinism: These findings are consistent with human studies in which estrogen-deficient men and women with Cyp19 aromatase deficiency and a male patient with ERα deficiency exhibited insulin resistance, impaired glucose metabolism, and hyperinsulinemia [22].